First-quarter revenue and Cologuard test volume increased 79 percent to $162 million and 334,000, respectively

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. APGE
7. ABBV
8. DFTX
9. USO
10. IBM

Go back to First-quarter revenue and Cologuard test volume increased 79 percent to $162 million and 334,000, respectively

Exact Sciences (EXAS) Misses Q1 EPS by 1c, Revs Beat; Raises Outlook

April 30, 2019 4:16 PM EDT

Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.66), $0.01 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $162 million versus the consensus estimate of $153.04 million.

GUIDANCE:

Exact Sciences sees FY2019 revenue of $725-740 million, versus prior of... More